Información del artículo
Objetivo
La finalidad del presente trabajo es divulgar entre los pediatras los factores de riesgo asociados al linfoma de Hodgkin (LH) durante las épocas pediátrica y adulta.
MétodosRevisión bibliográfica de los últimos 25 años obtenida principalmente del Medline, IAR Cancer y Cancerlit sobre los factores de riesgo de LH. Se han seleccionado los trabajos más interesantes y de sus referencias se han recuperado los más relevantes de los años previos a la búsqueda.
ResultadosLos principales factores de riesgo asociados con mayor o menor consistencia al desarrollo de LH son los siguientes: a) genéticos (variaciones en las regiones de la clase II HLA); b) infecciosos (virus de Epstein-Barr); c) ambiente infantil y clase social; d) inmunodeficiencias congénitas y adquiridas; e) condiciones médicas, y f) exposiciones profesionales (industria de la madera y derivados).
ConclusionesLa etiología de la mayoría de los LH es desconocida. Los factores de riesgo convincentemente asociados a un mayor riesgo de LH son: a) genético-familiares; b) virus de Epstein-Barr (mononucleosis infecciosa); c) inmunodeficiencias congénitas y adquiridas, y d) exposición ocupacional a la industria de la madera y derivados.
Palabras clave:
Factores de riesgo
Linfoma de Hodgkin
Virus de Epstein- Barr
Mononucleosis infecciosa
Inmunodeficiencias
Industria maderera
Objective
To divulge the risk factors associated with Hodgkin's lymphoma (HL) in children and adults among pediatricians.
MethodsWe performed a literature review of the last 25 years through the Medline, IAR Cancer, and Cancerlit databases. The search profile was “HL risk factors”. The most interesting papers, as well as those cited and published more than 25 years prior to the search, were selected.
ResultsThe following risk factors for HL were reported with greater or lesser evidence: a) genetic (variation in the HLA class II region); b) viral infections (Epstein-Barr virus); c) childhood environment and socio-economic status; d) congenital and acquired immunodeficiency; e) medical conditions and f) occupational exposure (the wood industry and its derivatives).
ConclusionsThe etiology of most HL is unknown. The most important risk factors are: 1) genetic; 2) Epstein-Barr virus (infectious mononucleosis); 3) congenital and acquired immunodeficiency; 4) occupational exposure (the wood industry).
Key words:
Risk factors
Hodgkin's Lymphoma
Epstein-Barr virus
Infectious mononucleosis
Immunodeficiency
Wood industry
El Texto completo está disponible en PDF
Bibliografía
[1.]
Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL et al, eds. Cancer incidence and survival among children and adolescent: United States SEER Program 1975–1995. National Cancer Institute, SEER Program. Bethesda: NIH, 1999; Pub. n.° 99–4649.
[2.]
J.H. Sandlund.
Childhood lymphoma.
Clinical oncology, 2.ª edition, pp. 2435-2450
[3.]
N.J. Bunnin, M.D. Meadows.
Lymphoma in children.
Cancer Medicine, 4.ª ed, pp. 3035-3045
[4.]
M.M. Hudson, S.S. Donaldson.
Hodgkin's Disease.
Principles and practice of pediatric oncology, 3.ª ed, pp. 523-543
[5.]
D. Kaufman, D.L. Longo.
Hodgkin's Disease.
Clinical Oncology, 2.ª ed, pp. 2620-2657
[6.]
J. Little.
Epidemiology of childhood cancer. World Health Organization. International Agency for Research on Cancer.
IARC Sci, (1999),
[7.]
M.S. Linet, L.A.G. Ries, M.A. Smith, R.E. Tarone, S.S. Devesa.
Cancer Surveillance Series: recents trends in childhood cancer incidence and mortality in the United States.
J Natl Cancer Int, 91 (1999), pp. 1051-1058
[8.]
D. Baris, S.H. Zahm.
Epidemiology of lymphomas.
Cur Op Oncol, 12 (2000), pp. 383-394
[9.]
A. Harras, B.K. Edwards, W.S. Blot, L.A.G. Ries.
Cancer Rates and Risks. National Institutes of Health. National Cancer Institute.
NIH, (1996),
[10.]
N.E. Mueller.
Hodgkin's disease.
Cancer epidemiology and prevention, pp. 893-919
[11.]
C.A. Stiller.
What causes Hodgkin's disease in children?.
Eur J Cancer, 34 (1998), pp. 523-528
[13.]
Cancer incidence in five continents, Vol. VI. International Agency for Research on Cancer,
[14.]
G.M. Taylor, D.A. Gokhale, D. Crowther, et al.
Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggest an influence on susceptibility to different HD subtypes.
Br J Cancer, 80 (1999), pp. 1405-1411
[15.]
A. Chakravarti, S.L. Halloran, S.J. Bale, et al.
Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility indepent of histological concordance.
Genet Epidemiol, 3 (1986), pp. 407-415
[16.]
J. Hors, J. Dausset.
HLA and susceptibility to Hodgkin's disease.
Immunol Rev, 70 (1983), pp. 167-191
[17.]
T.M. Mack, W. Cozen, D.K. Shibata, L.M. Weiss, B.N. Nathwari, A.M. Hernandez, et al.
Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease.
N Engl J Med, 332 (1995), pp. 413-418
[18.]
S. Grufferman, P. Cole, P.G. Smith, et al.
Hodgkin's disease in sibling.
N Engl J Med, 296 (1977), pp. 248-250
[19.]
A.M. Ferraris, O. Racchi, D. Rapezzi, et al.
Familial Hodgkin's disease: a disease of young adulthood?.
Ann Hematol, 74 (1997), pp. 131-134
[20.]
N.J. Vianna, P. Greenwald, J.N.P. Davies.
Extended epidemic of Hodgkin's disease in high school student.
Lancet, 1 (1971), pp. 1209-1211
[21.]
B. Mac Mahon.
Epidemiological evidence on the nature of Hodgkin's disease: Cancer, 10 (1957), pp. 1045-1054
[22.]
R.J. Klinger, J.P. Minton.
Case clustering of Hodgkin's disease in a small rural community, with associations among cases.
Lancet, 1 (1973), pp. 168-171
[23.]
B.G. Sleckman, P.M. Mauch, R.F. Ambinder, R. Mann, G.S. Pinkus, M.E. Kadin, et al.
Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection.
Cancer Epidemiol Biomarkers Prev, 7 (1998), pp. 1117-1121
[24.]
S.L. Glaser, R.J. Lin, S.L. Stewart, R.F. Ambinder, R.F. Jarret, P. Brousset, et al.
Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.
Int J Cancer, 20 (1997), pp. 375-382
[25.]
A.A. Armstrong, F.E. Alexander, R. Cartwright, B. Angus, A.S. Krajewski, D.H. Wright, et al.
Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis.
Leukemia, 12 (1998), pp. 1272-1276
[26.]
A.A. Armstrong, F.E. Alexander, R.P. Paes, N.A. Morad, A. Gallagher, A.S. Krajewski, et al.
Association of Epstein-Barr virus with pediatric Hodgkin's disease.
Am J Pathol, 142 (1993), pp. 1683-1688
[27.]
A.S. Evans, N.M. Gutensohn.
A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their sibling.
Int J Cancer, 34 (1984), pp. 149-157
[28.]
N. Mueller, A. Evans, N.L. Harris, G.W. Comstock, E. Jellum, K. Magnus.
Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis.
N Engl J Med, 320 (1989), pp. 689-695
[29.]
R. Ambinder, P. Browning, I. Lorenzana, B.G. Leventhal, H. Cosenza, R.B. Mann, et al.
Epstein-Barr virus and childhood Hodgkin's disease in Honduras and United States.
Blood, 81 (1993), pp. 462-467
[30.]
G. Pallesen, S.J. Hamilton-Dutoit, M. Rowe, L.S. Young.
Expression of Epstein-Barr virus latent gene products in tumors cells of Hodgkin's disease.
Lancet, 337 (1991), pp. 320-322
[31.]
S.M. Bernard, R.A. Cartwright, C.M. Darwin, I.D. Richards, B. Roberts, C. O Brien.
Hodgkin's disease: case control epidemiological study in Yorkshire.
Br J Cancer, 55 (1987), pp. 85-90
[32.]
D. Serraino, S. Franceschi, E. Talamani, S. Barra, E. Negri, A. Carbone, et al.
Socioeconomic indicators, infectious diseases and Hodgkin's disease.
Int J Cancer, 47 (1991), pp. 352-357
[33.]
N.M. Gutensohn.
Social class and age at diagnosis of Hodgkin's disease: New epidemiologic evidence for the “two-disease hypothesis”.
Cancer Treat Rep, 66 (1982), pp. 689-695
[34.]
T. Lehtinen, J. Lumio, J. Dillner, M. Hakama, P. Knekt, M. Lehtinen, et al.
Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies. A prospective study.
Cancer Causes Control, 4 (1993), pp. 187-193
[35.]
H. Uhara, Y. Sato, K. Mukai, I. Akao, Y. Matsuno, S. Furuya.
Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin's disease using the polymerase chain reaction and in situ hybridization.
Japn J Cancer Res, 81 (1990), pp. 272-278
[36.]
G. Khan, A.J. Norton, G. Slavin.
Epstein-Barr virus in Hodgkin's disease: relation to age and subtype.
Cancer, 71 (1993), pp. 3124-3129
[37.]
P. Levine, P. Ebbesen, D.V. Ablashi, W.C. Saxinger, A. Nordentoft, R.R. Connelly, et al.
Antibodies to human herpes virus-6 and clinical course in patients with Hodgkin's disease.
Int J Cancer, 51 (1992), pp. 53-57
[38.]
N.M. Gutensohn, D.S. Shapiro.
Social class risk factors among children with Hodgkin's disease.
Int J Cancer, 30 (1982), pp. 433-435
[39.]
B.M. Cohen, H.E. Smetana, R.W. Miller.
Hodgkin's disease: long survival in a study of 388 world war II army cases.
Cancer, 17 (1964), pp. 856-866
[40.]
N.M. Gutensohn, P. Cole.
Epìdemiology of Hodgkin's disease in the young.
Int J Cancer, 19 (1977), pp. 595-604
[41.]
N.M. Gutensohn, P. Cole.
Childhood social enviroment and Hodgkin's disease.
N Engl J Med, 304 (1981), pp. 135-140
[42.]
J.H. Abramson, H. Pridan, M. Sacks, M. Avitzour, E. Peritz.
A case-control study of Hodgkin's disease in Israel.
J Natl Cancer Inst, 61 (1978), pp. 307-314
[43.]
P.A. Rowlings, R.E. Curtis, J.R. Passweg, H.J. Deeg, G. Socie, L.B. Travis, et al.
Increased incidence of Hodgkin's disease after allogenic bone marrow transplantation.
J Clin Oncol, 17 (1999), pp. 3122-3127
[44.]
A.G.R. Sheil.
Cancer in organ transplant recipients: part of an induced immune deficiency syndrome.
Brit Med J, 288 (1984), pp. 659-661
[45.]
T.J. Doyle, K.K. Venkatachalam, K. Maeda, S.M. Saeed, E.J. Tilchen, et al.
Hodgkin's disease in renal transplant recipients.
Cancer, 51 (1983), pp. 245-247
[46.]
A.H. Filipovich, B.C. Spector, J. Kersey.
Immunodeficiency in humans as a risk factor in the development of malignancy.
Prev Med, 9 (1980), pp. 252-259
[47.]
A.F. List, F.A. Greco, L.B. Vogler.
Lympholiferative diseases in immunocompromised host: the role of Epstein-Barr virus.
J Clin Oncol, 5 (1987), pp. 1673-1689
[48.]
F.S. Rosen, M.D. Cooper, R.J.P. Wedgwood.
The primary immunodeficiencies.
N Engl J Med, 311 (1984), pp. 235-242
[49.]
A.E. Grulich.
AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy.
J Acquir Immune Defic Syndr, 21 (1999), pp. 27-30
[50.]
A. Petruckevitch, J. Del Amo, A.N. Phillips, J.M. Stephenson, A.M. Johnson, K.M. De Cock, et al.
Risk of cancer in patients with HIV disease.
Int J Stud AIDS, 10 (1999), pp. 38-42
[51.]
E. Chokunonga, L.M. Levy, M.T. Basset, M.Z. Borok, B.G. Mauchaza, M.Z. Chirenje, et al.
Aids and cancer in Africa: the envolving epidemic in Zimbabwe.
AIDS, 13 (1999), pp. 2583-2588
[52.]
N. Mueller, G.M. Swanson, C.C. Hsieh, et al.
Tonsillectomy and Hodgkin's disease: results from comparation population-based studies.
J Natl Cancer Int, 78 (1987), pp. 1-5
[53.]
L. Bonelli, V. Vitale, F. Bistolgi, M. Landucci, P. Bruzzi.
Hodgkin's disease in adults: association with social factors and age at tonsillectomy. A case-control study.
Int J Cancer, 45 (1990), pp. 423-427
[54.]
P. Paavolainen, E. Pukkala, P. Pulkkinen, T. Visuri.
Cancer incidence after total knee arthroplasty: a nationwide Finnish cohort from 1980 to 1996 involving 944 patients.
Acta Orthoped Scand, 70 (1999), pp. 609-617
[55.]
M.H. Greene, L.A. Brinton, J.H. Fraumeni Jr., R. D’Amico.
Familial and sporadic Hodgkin's disease associated with occupational wood exposure.
Lancet, 2 (1978), pp. 626-627
[56.]
G.R. Peterson, S. Milham Jr..
Hodgkin's disease mortality and occupational exposure to wood.
J Natl Cancer Inst, 53 (1974), pp. 957-958
[57.]
L.V. Kirchoff, A.S. Evans, K.E. McClelland, R.P. Carvalho, C.S. Pannuti.
A case-control study of Hodgkin's disease in Brazil. I. Epidemiologic aspects.
Ann J Epidemiol, 112 (1980), pp. 595-608
[58.]
R.J. Mc Cunney.
Hodgkin's disease, work, and the environment: a review.
J Occup Environ Med, 41 (1999), pp. 36-46
[59.]
S.A. Khuder, A.B. Mutgi, E.A. Schaub, B.D. Tano.
Meta-analysis of Hodgkin's disease among farmers.
Scan J Work Environ Health, 25 (1999), pp. 436-441
[60.]
C.F. Robinson, J.T. Walker.
Cancer mortality among women employed in fact-growing U.S. occupations.
Am J Int Med, 36 (1999), pp. 186-192
[61.]
P. Wilkinson, B. Thakrar, P. Walls, M. Landon, S. Falconer, C. Grundy, et al.
Lymphohaematopoietic malignancy around all industrial complexes that include major oil refineries in Great Britain.
Occup Environ Med, 56 (1999), pp. 577-580
[62.]
W.F. Dove.
Genes and Cancer: Risk determinants and agents of change.
Clinical Oncology, 2.ª ed, pp. 54-76
[63.]
K.A. Keefe, F.L. Meyskens Jr..
Cancer Prevention.
Clinical Oncology, 2.ª ed, pp. 318-365
Copyright © 2001. Asociación Española de Pediatría
